News | November 07, 2024
Vijaya Diagnostic Centre posts Q2 FY25 PAT at Rs. 41.95 Cr
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revenue growth was fueled by higher volumes and contributions from both existing and new centres
Revolf's infertility and miscarriage tests are a new technology that uses blood tests to detect neoself-antibodies
The workshop is specially curated for Ayurvedic medical officers from Delhi and Haryana
Acquisition enhances Freenome's product portfolio, including autoantibody platform with additional biomarkers important in cancer detection
The study concluded that elevated levels of two proteins help predict how a person will recover from a traumatic brain injury (TBI), providing important information to determine appropriate care
Lung cancer is the leading cause of cancer death in the USA, making up almost 25% of all cancer deaths
Blood test for early detection of Alzheimer's Disease (AD) risk will lead to better patient care, physicians say; US. adults call for earlier evaluation and more education
A simple blood test detects over 30 types of cancers
At the new centre, customers get a real-time experience of the process of genetic testing and actionable plans in preventive healthcare under the expertise of certified genetic counsellors
Three Indian firms namely Curisin, Immunidex and Telemedicine Indian company are part of the first phase
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
